Datasea Intelligent Technology Ltd. — Cyborg Score 3/10

Weak
Acoustic high-tech innovation and medical devices

Strategic Profile

The company is transitioning toward high-margin, solution-driven business lines with expected strong gross profit contribution from completed AI multimodal projects. Datasea is advancing preparatory compliance work for potential U.S. FDA establishment registration and device listing for an acoustic brain-computer interface product, with plans for systematic documentation, testing and regulatory communication to support its acoustic medical and BCI internationalization strategy. The company is advancing international commercialization of its acoustic AI wellness care robots and preparing a U.S. launch of acoustic disinfection products, with products and services deployed in >50 Chinese cities across ~300 locations.

Cyborg Score Rationale

Datasea generated approximately $12.995M in quarterly revenue but still lost roughly $0.54M, with the core business scaling but not yet profitable. The company shows a gross margin around 7.4%, which is very slim, with negative EBIT and return on equity signaling the company is still burning economic value even as sales grow. Regulatory risk, limited profitability path, and capital constraints define the risk profile.

Top Insights

  • Advancing FDA compliance work for acoustic brain-computer interface product with DUNS application and planned regulatory documentation (June 2026)
  • Completed delivery of three AI multimodal solution projects worth $1.01M (April 2026) with expected strong gross profit contribution
  • Announced foundational research breakthrough in ultrasonic-enhanced nanoscale precision control for next-generation semiconductor manufacturing (February 2026), currently in research phase
  • Redomiciled from Nevada to British Virgin Islands (April 2026), preserving Nasdaq DTSS listing with one-for-one share conversion

Named Competitors

  • Intuitive Surgical — Robotics-assisted surgical systems with AI integration
  • iRobot — AI-powered robotics and automation products
  • Medtronic Neuroscience — Neuromodulation and brain-computer interface research
  • Google Cloud AI — Multimodal AI and digital solution platforms

Recent Developments

  • (June 2026) Acquired cloud detection patent for RMB 7.0M (~$1.03M) via stock issuance
  • (April 2026) Completed delivery of three AI multimodal projects totaling $1.01M in contract value
  • (April 2026) Redomicile merger to British Virgin Islands completed; company continues trading as DTSS on Nasdaq
  • (March 2026) Achieved initial technical service revenue with Yizhimei Technology for acoustic + AI wellness care robots
  • (February 2026) Announced breakthrough in ultrasonic-enhanced nanoscale precision control technology

Open the full interactive Datasea Intelligent Technology Ltd. report

Strategic research, analyst-debate audio, full Cyborg Score breakdown across 11 dimensions, and saved-company audio playlists.

Open report →